150 related articles for article (PubMed ID: 36770773)
1. The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target.
Hu L; Liu Y; Fu C; Zhao J; Cui Q; Sun Q; Wang H; Lu L; Dai H; Xu X; Yang W
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770773
[TBL] [Abstract][Full Text] [Related]
2. Anchoring Filament Protein Ladinin-1 is an Immunosuppressive Microenvironment and Cold Tumor Correlated Prognosticator in Lung Adenocarcinoma.
Yuan K; Zhang Y; Yu Y; Xu Y; Xian S
Biochem Genet; 2023 Oct; 61(5):2173-2202. PubMed ID: 37005975
[TBL] [Abstract][Full Text] [Related]
3. Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma.
Chang CY; Huang YC; Chiang HH; Wu YY; Wu KL; Chang YY; Liu LX; Tsai YM; Hsu YL
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613882
[TBL] [Abstract][Full Text] [Related]
4. circ-ANXA7 facilitates lung adenocarcinoma progression via miR-331/LAD1 axis.
Wang Y
Cancer Cell Int; 2021 Feb; 21(1):85. PubMed ID: 33536022
[TBL] [Abstract][Full Text] [Related]
5. CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma.
He J; Lan X; Liu X; Deng C; Luo H; Wang Y; Kang P; Sun Z; Zhao L; Zhou X
BMC Cancer; 2023 Mar; 23(1):266. PubMed ID: 36959566
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
7. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
Tang X; Zhou H; Liu Y
Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
[No Abstract] [Full Text] [Related]
9. KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m
Lin X; Ye R; Li Z; Zhang B; Huang Y; Du J; Wang B; Meng H; Xian H; Yang X; Zhang X; Zhong Y; Huang Z
Drug Resist Updat; 2023 Jan; 66():100908. PubMed ID: 36493511
[TBL] [Abstract][Full Text] [Related]
10. Origin recognition complex subunit 1 (ORC1) augments malignant behaviors of lung adenocarcinoma cells via targeting Wnt signaling.
Han L; Li F
Bioengineered; 2022 May; 13(5):13520-13533. PubMed ID: 36700467
[TBL] [Abstract][Full Text] [Related]
11. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
12. High Expression of
Deng H; Huang Y; Wang L; Chen M
Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
[TBL] [Abstract][Full Text] [Related]
14. Integrative analyses identified ion channel genes GJB2 and SCNN1B as prognostic biomarkers and therapeutic targets for lung adenocarcinoma.
Lu A; Shi Y; Liu Y; Lin J; Zhang H; Guo Y; Li L; Lin Z; Wu J; Ji D; Wang C
Lung Cancer; 2021 Aug; 158():29-39. PubMed ID: 34111567
[TBL] [Abstract][Full Text] [Related]
15. Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients.
Huang P; Xu L; Jin M; Li L; Ke Y; Zhang M; Zhang K; Lu K; Huang G
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741714
[TBL] [Abstract][Full Text] [Related]
16. SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors.
Roth L; Srivastava S; Lindzen M; Sas-Chen A; Sheffer M; Lauriola M; Enuka Y; Noronha A; Mancini M; Lavi S; Tarcic G; Pines G; Nevo N; Heyman O; Ziv T; Rueda OM; Gnocchi D; Pikarsky E; Admon A; Caldas C; Yarden Y
Sci Signal; 2018 Jan; 11(515):. PubMed ID: 29382783
[TBL] [Abstract][Full Text] [Related]
17. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.
Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q
Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698
[TBL] [Abstract][Full Text] [Related]
18. LAD1 expression is associated with the metastatic potential of colorectal cancer cells.
Moon B; Yang SJ; Park SM; Lee SH; Song KS; Jeong EJ; Park M; Kim JS; Yeom YI; Kim JA
BMC Cancer; 2020 Dec; 20(1):1180. PubMed ID: 33267790
[TBL] [Abstract][Full Text] [Related]
19. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
Zhang X; Wu Z; Ma K
BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
[TBL] [Abstract][Full Text] [Related]
20. NOTCH3 Overexpression and Posttranscriptional Regulation by miR-150 Were Associated With EGFR-TKI Resistance in Lung Adenocarcinoma.
Zhang Y; Chen B; Wang Y; Zhao Q; Wu W; Zhang P; Miao L; Sun S
Oncol Res; 2019 Jul; 27(7):751-761. PubMed ID: 30732676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
